Pegasus to handle Buscopan for Boehringer Ingelheim

Pharma company Boehringer Ingelheim has appointed Pegasus to promote a treatment for irritable bowel syndrome.

IBS: Pegasus to promote treatment Buscopan (Credit: Thinkstock)
IBS: Pegasus to promote treatment Buscopan (Credit: Thinkstock)

The agency won the retained brief to deliver a UK PR programme for over-the-counter brand Buscopan following a four-way competitive pitch.

The brief centres on communicating to IBS sufferers the role of the product as an antispasmodic treatment as part of their ongoing management.

Associate director Chris Webb, who will lead the account at Pegasus, said the brief would involve providing practical help and support to IBS sufferers. ‘Not only will this reinforce the product as the gold standard treatment, but it will also help the brand build an emotional connection with IBS sufferers, supporting the more functional message delivered by the advertising,’ he said.

Pegasus will report to Buscopan brand manager Hazel Richards, who said the agency had demonstrated a strong understanding of the brand, the target audience and the media environment during the pitch process.

Would you like to post a comment?

Please Sign in or register.

News by email...